IP Verse

Safe Sequencing System - EP2697397

The patent EP2697397 was granted to The Johns Hopkins University on Apr 5, 2017. The application was originally filed on Apr 12, 2012 under application number EP12772013A. The patent is currently recorded with a legal status of "Revoked".

EP2697397

THE JOHNS HOPKINS UNIVERSITY
Application Number
EP12772013A
Filing Date
Apr 12, 2012
Status
Revoked
Oct 11, 2019
Grant Date
Apr 5, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEJan 5, 2018ADMISSIBLE
STRAWMANJan 3, 2018ADMISSIBLE
ROCHEDec 20, 2017ADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2003148335
INTERNATIONAL-SEARCH-REPORTUS2006263789
INTERNATIONAL-SEARCH-REPORTUS2007269805
INTERNATIONAL-SEARCH-REPORTUS6746845
OPPOSITIONUS2003148335
OPPOSITIONUS2006263789
OPPOSITIONUS2007020640
OPPOSITIONUS2007269805
OPPOSITIONUS2010129874
OPPOSITIONUS6746845
OPPOSITIONWO02059355
OPPOSITIONWO2009152928
OPPOSITIONWO2010126614
OPPOSITIONWO2010127186
OPPOSITIONWO2012038839
OPPOSITIONWO2012142213
SEARCHWO02059355
SEARCHWO2009152928

Non-Patent Literature (NPL) Citations (22) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "35 the ckeavase i enzyme for mutation and polymorphism scanning", INNIS, MICHAEL A. et al., PCR applications: protocols for functional genomics, (19990000), pages 537 - 550, ISBN 0080919634, XP055448749-
OPPOSITION- BAINBRIDGE et al., "Whole exome capture in solution with 3 Gbp ofdata", Genome Biology, (20100000), vol. 11, pages 1 - 8, XP055167629-
OPPOSITION- "consensus sequences", Wikipedia, (20110410), pages 1 - 2, XP055448731-
OPPOSITION- "exonuclease", THERMO SCIENTIFIC, ( ), pages 1 - 4, XP055450389-
OPPOSITION- Kivioja, "Counting absolute number of molecules using unique molecular identifiers", Nature Precedings, (20120000), pages 1 - 18, XP055448736-
OPPOSITION- KIVIOJA et al., "Counting absolute number of molecules using unique molecular identifiers", Nature Precedings, (20110414), pages 1 - 18, XP055448736-
OPPOSITION- Kraytsberg ET AL, "Single-molecule PCR: an artifact-free PCR approach for the analysis of somatic mutations", Future Drugs Ltd, (20050000), vol. 5, no. 5, pages 809 - 815, XP055450406-
OPPOSITION- "Polymerase chain reaction", Wikipedia, (20110129), pages 1 - 13, URL: https://en.wikipedia.org/w/index.php?title=Polymerase_chain_reaction&oldid=410799584, XP055450412-
OPPOSITION- LINNARSSON, "Recent advances in DNA sequencing methods - general principles of sample preparation", Experimental Cell Research, (20100000), vol. 316, pages 1339 - 1343, XP055087319
OPPOSITION- Kraytsberg ET AL, "Single molecule PCR in mtDNA mutational analysis: Genuine mutations vs. damage bypass-derived artifacts", Methods, (20080000), vol. 46, no. 4, pages 269 - 273, XP025681208
OPPOSITION- Hiatt ET AL, "Parallel, tag-directed assembly of locally derived short sequence reads (+ Online Methods)", Nature Methods, (20100000), vol. 7, no. 2, pages 119 - 122, XP055005905
OPPOSITION- METZKER, "Sequencing technologies - the next generation", Nat Rev. Genet., (20100000), vol. 11, pages 31 - 46, XP055256196
OPPOSITION- KINDE 1. et al., "Detection and quantification of rare mutations with massively parallel sequencing", Proc. Natl. Acad. Sci. USA., (20110607), vol. 108, no. 23, pages 9530 - 9535, XP055164202
OPPOSITION- Kinde ET AL, "Detection and quantification of rare mutations with massively parallel sequencing", Proceedings of the National Academy of Sciences,, (20110000), vol. 108, no. 23, pages 9530 - 9535, XP055164202
OPPOSITION- Casbon ET AL, "A method for counting PCR template molecules with application to next-generation sequencing", Nucleic Acids Research, (20110000), vol. 39, no. 12, pages 1 - 8, XP002666160
OPPOSITION- CASBON J.A. et al., "A method for counting PCR template molecules with application to next-generation sequencing", Nucleic Acids Res., (20110413), vol. 39, no. 12, pages 1 - 8, XP002666160
OPPOSITION- FULLWOOD et al., "Next ... generation DNA sequencing of paired ... end tags(PET) for transcripton1e and genome analyses", Genome Res., (20090000), vol. 19, pages 521 - 532, XP055015048
OPPOSITION- ZILBERMAN et al., "Genome-wide analysis of DNA methylation patterns", Development, (20070000), vol. 134, pages 3959 - 3965, XP002614667
OPPOSITION- Binladen ET AL, "The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing", PLoS ONE, (20070000), vol. 2, no. 2, pages 1 - 9, XP002732340
OPPOSITION- BINLADEN J. et al., "The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing", PLoS One, (20070214), vol. 2, no. 2, pages 1 - 9, XP002732340
OPPOSITION- BELL, "A simple way to treat PCR products prior to sequencing using ExoSAP-IT", Biotechniques, (20080000), vol. 44, no. 6, page 834, XP001538198
SEARCH- KIVIOJA TEEMU ET AL, "Counting absolute numbers of molecules using unique molecular identifiers.", NATURE METHODS JAN 2012, (201201), vol. 9, no. 1, ISSN 1548-7105, pages 72 - 74, XP002729237 [XP] 8,9 * abstract * [I] 1-7,10-18

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents